Lifitegrast

Aurobindo Pharma Limited🇺🇸 United States

FDA Page

Effective Date: Nov 13, 2023
Approval ID: 1d4b4b61-79da-4b6f-bb19-056d111bf400
Products: 1 registered
Version: 1

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use LIFITEGRAST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LIFITEGRAST OPHTHALMIC SOLUTION. LIFITEGRAST ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 2016

Quick Stats

Total Products1

Labelers2

Label Sections16

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.